CanSino Biologics announced on November 27, 2024, that its new vaccine PBPV had made important progress in Phase III clinical trials. The vaccine aims to prevent specific diseases and has been tested in multiple regions. CEO Yu Xuefeng stated that this development marks another important milestone for the company in the field of vaccine development. The company is expected to further announce trial data on December 1, 2024, and plans to apply for relevant market approvals in the coming months. Due to the enormous potential market demand for the vaccine, CanSino Biologics holds an optimistic outlook for future sales prospects. The company will continue to focus on innovation and research and development to maintain its leading position in the biopharmaceutical industry. In addition, CanSino Biologics emphasized strengthening cooperation with global partners to accelerate the commercialization process of the vaccine. This measure will not only help enhance the company's international influence but also contribute to global public health.

CanSino Biologics announced on November 27, 2024, that its new vaccine PBPV had made important progress in Phase III clinical trials. The vaccine aims to prevent specific diseases and has been tested in multiple regions. CEO Yu Xuefeng stated that this development marks another important milestone for the company in the field of vaccine development. The company is expected to further announce trial data on December 1, 2024, and plans to apply for relevant market approvals in the coming months. Due to the enormous potential market demand for the vaccine, CanSino Biologics holds an optimistic outlook for future sales prospects. The company will continue to focus on innovation and research and development to maintain its leading position in the biopharmaceutical industry. In addition, CanSino Biologics emphasized strengthening cooperation with global partners to accelerate the commercialization process of the vaccine. This measure will not only help enhance the company's international influence but also contribute to global public health.